GLP1R and osteoarthritis: Meanwhile, the use of a GLP-1 receptor agonist activated the PKA/CREB pathway to exhibit anti-inflammatory activity in a rat model of osteoarthritis, suggesting that GLP-1 may be associated with the formation of the skeletal senescence microenvironment and influence the onset of degenerative bone diseases (43).